Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +27 more
Locations
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858

Conditions
Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Trovare Clinical Research Bakersfield, California, United States
  • Tower Urology Los Angeles, California, United States
  • Chesapeake Urology Associates Hanover, Maryland, United States
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

NCT04068896

Conditions
Adnexal Diseases, Bladder Cancer, Bronchial Neoplasms, +69 more
Locations
  • NGM Clinical Study Site Tucson, Arizona, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Los Angeles, California, United States
  • NGM Clinical Study Site Sacramento, California, United States
View all 20 locations
View Trial Details
Completed

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

NCT04383938

Conditions
Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

CD155 in Bladder Cancer

NCT03789682

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions